Linked Life Data

21563549

Source:http://linkedlifedata.com/resource/pubmed/id/21563549

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2011-5-12
pubmed:abstractText
Advanced salivary gland cancer is a rare disease that comprises different histopathological tumour types; correspondingly, data on palliative systemic treatment are scarce. Combination chemotherapy with cyclophosphamide, doxorubicin, and cisplatin (CAP) has been reported to induce a reasonable response rate, although fewer than 100 cases have been described. We conducted a retrospective review of advanced salivary gland cancer patients treated with CAP.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1781-782X
pubmed:author
pubmed:issnType
Print
pubmed:volume
7
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1-6
pubmed:meshHeading
pubmed:year
2011
pubmed:articleTitle
Cyclophosphamide, doxorubicin, and cisplatin in advanced salivary gland cancer.
pubmed:affiliation
Department of General Medical Oncology, Leuven Cancer Institute, University Hospitals Leuven, Catholic University Leuven, Belgium.
pubmed:publicationType
Journal Article